Percutaneous transluminal coronary angioplasty. Initial Mayo Clinic experience

R. E. Vlietstra, David Holmes, H. C. Smith, G. O. Hartzler, T. A. Orszulak

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Percutaneous transluminal coronary angioplasty is a promising new method of treatment for patients with coronary artery disease. Inflation of a balloon located at the tip of a catheter is used to dilate stenoses. In the first year of the use of percutaneous transluminal coronary angioplasty at the Mayo Clinic, it was applied in 34 selected patients whose severe angina pectoris was related to a single, high-grade coronary artery stenosis. Successful dilation (stenosis opened by 40% or more of the normal luminal diameter) was achieved in 22 patients (65% of the total). Early postangioplasty assessment indicated relief of angina in all of these patients except for one patient who demonstrated coronary spasm that was responsive to medication. Median hospital stay was 3 days. Failure of percutaneous transluminal coronary angioplasty in the remaining 12 patients was usually due to an inability to manipulate the balloon catheter across the stenotic segment. Eleven of these patients had saphenous vein bypass graft surgery, as planned, immediately after the attempted angioplasty. There have been no deaths, but three patients sustained a transmural myocardial infarction. This initial experience with percutaneous transluminal coronary angioplasty indicates that it is a relatively safe and a frequently effective method of relieving coronary stenosis in selected patients with symptomatic coronary artery disease.

Original languageEnglish (US)
Pages (from-to)287-293
Number of pages7
JournalMayo Clinic proceedings
Volume56
Issue number5
StatePublished - Dec 1 1981
Externally publishedYes

Fingerprint

Coronary Balloon Angioplasty
Coronary Stenosis
Coronary Artery Disease
Pathologic Constriction
Catheters
Economic Inflation
Saphenous Vein
Spasm
Angina Pectoris
Angioplasty
Dilatation
Length of Stay
Myocardial Infarction
Transplants

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Vlietstra, R. E., Holmes, D., Smith, H. C., Hartzler, G. O., & Orszulak, T. A. (1981). Percutaneous transluminal coronary angioplasty. Initial Mayo Clinic experience. Mayo Clinic proceedings, 56(5), 287-293.

Percutaneous transluminal coronary angioplasty. Initial Mayo Clinic experience. / Vlietstra, R. E.; Holmes, David; Smith, H. C.; Hartzler, G. O.; Orszulak, T. A.

In: Mayo Clinic proceedings, Vol. 56, No. 5, 01.12.1981, p. 287-293.

Research output: Contribution to journalArticle

Vlietstra, RE, Holmes, D, Smith, HC, Hartzler, GO & Orszulak, TA 1981, 'Percutaneous transluminal coronary angioplasty. Initial Mayo Clinic experience', Mayo Clinic proceedings, vol. 56, no. 5, pp. 287-293.
Vlietstra RE, Holmes D, Smith HC, Hartzler GO, Orszulak TA. Percutaneous transluminal coronary angioplasty. Initial Mayo Clinic experience. Mayo Clinic proceedings. 1981 Dec 1;56(5):287-293.
Vlietstra, R. E. ; Holmes, David ; Smith, H. C. ; Hartzler, G. O. ; Orszulak, T. A. / Percutaneous transluminal coronary angioplasty. Initial Mayo Clinic experience. In: Mayo Clinic proceedings. 1981 ; Vol. 56, No. 5. pp. 287-293.
@article{3ebf476af270474aa84548538c4d2bbd,
title = "Percutaneous transluminal coronary angioplasty. Initial Mayo Clinic experience",
abstract = "Percutaneous transluminal coronary angioplasty is a promising new method of treatment for patients with coronary artery disease. Inflation of a balloon located at the tip of a catheter is used to dilate stenoses. In the first year of the use of percutaneous transluminal coronary angioplasty at the Mayo Clinic, it was applied in 34 selected patients whose severe angina pectoris was related to a single, high-grade coronary artery stenosis. Successful dilation (stenosis opened by 40{\%} or more of the normal luminal diameter) was achieved in 22 patients (65{\%} of the total). Early postangioplasty assessment indicated relief of angina in all of these patients except for one patient who demonstrated coronary spasm that was responsive to medication. Median hospital stay was 3 days. Failure of percutaneous transluminal coronary angioplasty in the remaining 12 patients was usually due to an inability to manipulate the balloon catheter across the stenotic segment. Eleven of these patients had saphenous vein bypass graft surgery, as planned, immediately after the attempted angioplasty. There have been no deaths, but three patients sustained a transmural myocardial infarction. This initial experience with percutaneous transluminal coronary angioplasty indicates that it is a relatively safe and a frequently effective method of relieving coronary stenosis in selected patients with symptomatic coronary artery disease.",
author = "Vlietstra, {R. E.} and David Holmes and Smith, {H. C.} and Hartzler, {G. O.} and Orszulak, {T. A.}",
year = "1981",
month = "12",
day = "1",
language = "English (US)",
volume = "56",
pages = "287--293",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "5",

}

TY - JOUR

T1 - Percutaneous transluminal coronary angioplasty. Initial Mayo Clinic experience

AU - Vlietstra, R. E.

AU - Holmes, David

AU - Smith, H. C.

AU - Hartzler, G. O.

AU - Orszulak, T. A.

PY - 1981/12/1

Y1 - 1981/12/1

N2 - Percutaneous transluminal coronary angioplasty is a promising new method of treatment for patients with coronary artery disease. Inflation of a balloon located at the tip of a catheter is used to dilate stenoses. In the first year of the use of percutaneous transluminal coronary angioplasty at the Mayo Clinic, it was applied in 34 selected patients whose severe angina pectoris was related to a single, high-grade coronary artery stenosis. Successful dilation (stenosis opened by 40% or more of the normal luminal diameter) was achieved in 22 patients (65% of the total). Early postangioplasty assessment indicated relief of angina in all of these patients except for one patient who demonstrated coronary spasm that was responsive to medication. Median hospital stay was 3 days. Failure of percutaneous transluminal coronary angioplasty in the remaining 12 patients was usually due to an inability to manipulate the balloon catheter across the stenotic segment. Eleven of these patients had saphenous vein bypass graft surgery, as planned, immediately after the attempted angioplasty. There have been no deaths, but three patients sustained a transmural myocardial infarction. This initial experience with percutaneous transluminal coronary angioplasty indicates that it is a relatively safe and a frequently effective method of relieving coronary stenosis in selected patients with symptomatic coronary artery disease.

AB - Percutaneous transluminal coronary angioplasty is a promising new method of treatment for patients with coronary artery disease. Inflation of a balloon located at the tip of a catheter is used to dilate stenoses. In the first year of the use of percutaneous transluminal coronary angioplasty at the Mayo Clinic, it was applied in 34 selected patients whose severe angina pectoris was related to a single, high-grade coronary artery stenosis. Successful dilation (stenosis opened by 40% or more of the normal luminal diameter) was achieved in 22 patients (65% of the total). Early postangioplasty assessment indicated relief of angina in all of these patients except for one patient who demonstrated coronary spasm that was responsive to medication. Median hospital stay was 3 days. Failure of percutaneous transluminal coronary angioplasty in the remaining 12 patients was usually due to an inability to manipulate the balloon catheter across the stenotic segment. Eleven of these patients had saphenous vein bypass graft surgery, as planned, immediately after the attempted angioplasty. There have been no deaths, but three patients sustained a transmural myocardial infarction. This initial experience with percutaneous transluminal coronary angioplasty indicates that it is a relatively safe and a frequently effective method of relieving coronary stenosis in selected patients with symptomatic coronary artery disease.

UR - http://www.scopus.com/inward/record.url?scp=0019795323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019795323&partnerID=8YFLogxK

M3 - Article

C2 - 7230894

AN - SCOPUS:0019795323

VL - 56

SP - 287

EP - 293

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 5

ER -